Starboard Value
Starboard Value LP is a New York-based investment adviser with a focused and differentiated fundamental approach to investing in publicly traded U.S. small cap companies. Starboard invests in deeply undervalued small cap companies and actively engages with management teams and boards of directors to identify and execute on opportunities to unlock value for the benefit of all shareholders.
View Older Stories View More Recent Stories
-
Form DFAN14A NEWS CORP Filed by: Starboard Value LP
-
Form DFAN14A NEWS CORP Filed by: Starboard Value LP
-
Leading Proxy Advisory Firms in the United States and Australia – ISS, Glass Lewis, Egan-Jones, and Ownership Matters – Unanimously Recommend Shareholders Vote FOR Starboard’s Proposal to Elimin
-
Kenvue's falling skin health sales hit earnings again
-
Match forecasts lackluster revenue as Tinder turnaround takes longer
-
Irenic Capital to Support Elimination of News Corp’s Dual-Class Share Structure
-
News Corp shareholders urged to end dual-class voting structure by more firms
-
ISS urges News Corp investors to back plan to collapse dual-class voting structure
-
Pfizer (PFE) Meeting With Starboard Was Constructive, Cordial - CEO Bourla
-
Pfizer CEO defends turnaround strategy as activist pressures management
-
Pfizer management looks to show turnaround as Starboard looms
-
Corvex founder Meister sees big upside for stocks already targeted by others
-
Starboard Value CEO says Pfizer's board should hold management accountable
-
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2024 Active-Passive Investor Summit
-
Starboard says Kenvue's skin health segment weighing on performance
-
Starboard Value Issues Presentation Delivered at 13D Monitor’s 2024 Active-Passive Investor Summit
-
Starboard takes stake in consumer products maker Kenvue, sources say
-
Starboard Value Builds Stake In Tylenol-Maker Kenvue - WSJ
-
Pfizer taps Vanguard veteran for board amid fight with Starboard
-
BofA analysts say "infrequent customers" are hitting sales at this coffee chain
-
Form DEFC14A NEWS CORP Filed by: Starboard Value LP
-
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
-
Starboard Value Issues Letter to Pfizer’s (PFE) Board of Directors
-
Starboard Value Issues Letter to Pfizer’s Board of Directors
-
Former Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
-
Statement From Former Pfizer CEO Ian Read and Former Pfizer CFO Frank D’Amelio Regarding Starboard Value
-
Pfizer CEO plans to meet activist investor Starboard, FT reports
-
Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
-
Tinder-parent Match names insider Steven Bailey as new CFO
-
Pfizer (PFE) PT Raised to $31 at CFRA
-
BMO Capital Reiterates Outperform Rating on Pfizer (PFE)
-
Wall Street indexes slip with interest rates, Middle East in focus
-
Activist Starboard Value Takes $1B Stake In Pfizer (PFE) - WSJ
-
Activist investor Starboard Value takes $1 billion stake in Pfizer, sources say
-
Form D/A Starboard Value & Opport
-
Form D/A Starboard Value & Opport
-
Form PREC14A NEWS CORP Filed by: Starboard Value LP
-
Form DFAN14A NEWS CORP Filed by: Starboard Value LP
-
Starboard Value Issues Letter to News Corp (NWSA) Shareholders
-
Starboard proposes that News Corp eliminates dual-class shares
-
Starboard Value Issues Letter to News Corp (NWSA) Shareholders Regarding a Proposal to Eliminate the Company’s Dual-Class Share Structure at the 2024 Annual Meeting
-
Starboard Value Issues Letter to News Corp Shareholders Regarding a Proposal to Eliminate the Company’s Dual-Class Share Structure at the 2024 Annual Meeting
-
Starboard Value Makes Nonbinding Proposal to End Murdoch's Control of News Corp (NWSA) - NYT
-
Exclusive-Starboard files proposal at News Corp, seeks to break Murdoch's grip
-
Form N-PX Starboard Value GP LLC For: Jun 30
-
Form N-PX Starboard Value LP For: Jun 30
-
Autodesk raises annual revenue and profit forecasts on strong design software demand
-
Morgan Stanley sees a 'favorable entry ahead of multiple catalysts' in this software stock
-
Rosenblatt Reiterates Buy Rating on Autodesk (ADSK)
-
Starboard Reiterates Call for Significant Change at Autodesk (ADSK) Following Reports of Senior Executives Intentionally Misleading Shareholders


